arrow_back Trending Legislation
Share share

Countering Captagon and Narcotics Post-Assad Act

This bill updates the U.S. strategy to disrupt illegal drug production and trafficking in the Middle East, focusing on substances like Captagon. It aims to increase regional stability and protect citizens by dismantling criminal networks linked to extremist groups.
Key points
Updates the strategy to target drug networks following the fall of the Assad regime.
Requires a public, unclassified plan to track and identify major drug shipments.
Evaluates the ability of Middle Eastern countries to stop drug smuggling and production.
Targets criminal networks linked to Hezbollah and other Iran-backed proxy groups.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Countering Captagon and Narcotics Post-Assad Act
Print number: HR 7180
Sponsor: Rep. Hill, J. French [R-AR-2]
Process start date: 2026-01-21
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Countering Captagon and Narcotics Post-Assad Act

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 7180.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2026-01-21.

What are the main provisions?

Key points include:

  • Updates the strategy to target drug networks following the fall of the Assad regime.
  • Requires a public, unclassified plan to track and identify major drug shipments.
  • Evaluates the ability of Middle Eastern countries to stop drug smuggling and production.
  • Targets criminal networks linked to Hezbollah and other Iran-backed proxy groups.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Hill, J. French [R-AR-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Foreign Affairs.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-02-10.

Analysis and Potential Impact of HR 7180

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Security